US Stocks

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals is a biopharmaceutical company that focuses on discovering and developing medicines related to cellular metabolism and adjacent areas of biology. The company offers PYRUKYND and AG-946 which are activators of wild-type and various mutant pyruvate kinase enzymes for treating hemolytic anemias and other related indications. Agios Pharmaceuticals was founded in 2007 and is based in Cambridge, Massachusetts.